Exciting News: We are joining forces with BIOMEX 🚀 We are proud to announce that we have joined the BIOMEX family, Europe’s leading provider of human biospecimens for the diagnostics and life science industries. Our values of competence, vision and sustainability perfectly align with BIOMEX´s mission of empowering scientists. As we begin this new chapter, we would like to express our warm thanks to all our partners and customers who have accompanied us on our journey so far. Your support and trust have been invaluable, and we look forward to taking our partnership with BIOMEX to a new level. Stay tuned for more updates and developments. #BIOMEX#EmpoweringScientists#LifeSciences
Info
Provitro stands for more than ten years of experience in commercialisation of cell culture technologies and tissue microarrays backed up by scientific knowledge and resources of immunohistochemical analyses at the Pathological Institute of Charité Universitätsmedizin Berlin. We have added medical research to our own know-how in biotechnology to create solutions to common problems in life sciences. Provitro’s team has raised its sights to the interface between research and development to hammer out brand-new solutions to the benefit of future research projects. These are our hallmarks: competence, vision and sustainability. Based on our quality management system certified according to ISO 9001 and ISO 13485, we are prepared to provide our customers not only with high-quality products and state-of-the-art services but also with individual solutions for their specific needs.
- Website
-
https://provitro.com/
Externer Link zu provitro AG
- Branche
- Biotechnologieforschung
- Größe
- 11–50 Beschäftigte
- Hauptsitz
- Berlin
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
Orte
-
Primär
Wegbeschreibung
Charitéplatz 1
Berlin, 10117, DE